Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 5
2004 2
2005 9
2006 11
2007 10
2008 9
2009 7
2010 3
2011 1
2012 4
2013 5
2014 11
2015 9
2016 10
2017 8
2018 4
2019 7
2020 6
Text availability
Article attribute
Article type
Publication date

Search Results

117 results
Results by year
Filters applied: . Clear all
Page 1
Recent advances in developing PCSK9 inhibitors for lipid-lowering therapy.
Lavecchia A, Cerchia C. Lavecchia A, et al. Future Med Chem. 2019 Mar;11(5):423-441. doi: 10.4155/fmc-2018-0294. Epub 2019 Mar 20. Future Med Chem. 2019. PMID: 30892945 Review.
Deep learning in drug discovery: opportunities, challenges and future prospects.
Lavecchia A. Lavecchia A. Drug Discov Today. 2019 Oct;24(10):2017-2032. doi: 10.1016/j.drudis.2019.07.006. Epub 2019 Aug 1. Drug Discov Today. 2019. PMID: 31377227 Review.
N-Formyl Peptide Receptors Induce Radical Oxygen Production in Fibroblasts Derived From Systemic Sclerosis by Interacting With a Cleaved Form of Urokinase Receptor.
Napolitano F, Rossi FW, Pesapane A, Varricchio S, Ilardi G, Mascolo M, Staibano S, Lavecchia A, Ragno P, Selleri C, Marone G, Matucci-Cerinic M, de Paulis A, Montuori N. Napolitano F, et al. Among authors: lavecchia a. Front Immunol. 2018 Apr 4;9:574. doi: 10.3389/fimmu.2018.00574. eCollection 2018. Front Immunol. 2018. PMID: 29670612 Free PMC article.
Selective PPARγ modulators for Type 2 diabetes treatment: how far have we come and what does the future hold?
Lavecchia A, Cerchia C. Lavecchia A, et al. Future Med Chem. 2018 Apr 1;10(7):703-705. doi: 10.4155/fmc-2018-0021. Epub 2018 Apr 19. Future Med Chem. 2018. PMID: 29671628 No abstract available.
Isoxazole-Based-Scaffold Inhibitors Targeting Cyclooxygenases (COXs).
Perrone MG, Vitale P, Panella A, Ferorelli S, Contino M, Lavecchia A, Scilimati A. Perrone MG, et al. Among authors: lavecchia a. ChemMedChem. 2016 Jun 6;11(11):1172-87. doi: 10.1002/cmdc.201500439. Epub 2016 May 2. ChemMedChem. 2016. PMID: 27136372
Small Molecule Drugs and Targeted Therapy for Melanoma: Current Strategies and Future Directions.
Cerchia C, Lavecchia A. Cerchia C, et al. Among authors: lavecchia a. Curr Med Chem. 2017;24(21):2312-2344. doi: 10.2174/0929867324666170414163937. Curr Med Chem. 2017. PMID: 28413965 Review.
Machine-learning approaches in drug discovery: methods and applications.
Lavecchia A. Lavecchia A. Drug Discov Today. 2015 Mar;20(3):318-31. doi: 10.1016/j.drudis.2014.10.012. Epub 2014 Nov 4. Drug Discov Today. 2015. PMID: 25448759 Review.
In silico methods to address polypharmacology: current status, applications and future perspectives.
Lavecchia A, Cerchia C. Lavecchia A, et al. Drug Discov Today. 2016 Feb;21(2):288-98. doi: 10.1016/j.drudis.2015.12.007. Epub 2015 Dec 29. Drug Discov Today. 2016. PMID: 26743596 Review.
Development of Novel Amides as Noncovalent Inhibitors of Immunoproteasomes.
Ettari R, Cerchia C, Maiorana S, Guccione M, Novellino E, Bitto A, Grasso S, Lavecchia A, Zappalà M. Ettari R, et al. Among authors: lavecchia a. ChemMedChem. 2019 Apr 17;14(8):842-852. doi: 10.1002/cmdc.201900028. Epub 2019 Mar 26. ChemMedChem. 2019. PMID: 30829448
Structure-Based Design, Synthesis, and In Vivo Antinociceptive Effects of Selective A1 Adenosine Receptor Agonists.
Petrelli R, Scortichini M, Belardo C, Boccella S, Luongo L, Capone F, Kachler S, Vita P, Del Bello F, Maione S, Lavecchia A, Klotz KN, Cappellacci L. Petrelli R, et al. Among authors: lavecchia a. J Med Chem. 2018 Jan 11;61(1):305-318. doi: 10.1021/acs.jmedchem.7b01399. Epub 2018 Jan 3. J Med Chem. 2018. PMID: 29257884
117 results
Jump to page